COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 323: Articles 3221-3230  | Next

Comparison of COVID-19 and Influenza-Related Outcomes in the United States during Fall-Winter 2022-2023
Kopel, H., Bogdanov, A., Winer-Jones, J., Adams, C., Winer, I., Bonafede, M., Nguyen, V. H., Mansi, J. A.
10.1101/2023.09.08.23295262 — Posted: 2023-09-11
A Bayesian approach to identifying the role of hospital structure and staff interactions in nosocomial transmission of SARS-CoV-2
Bridgen, J. R. E., Lewis, J. M., Todd, S., Taegtmeyer, M., Read, J. M., Jewell, C. P.
10.1101/2023.09.11.23295353 — Posted: 2023-09-11
The high infectivity of the SARS-CoV-2 Omicron variant is associated with an exclusive S477N spike receptor-binding domain mutation
Santos, J. C., Tamarozzi, E., Dametto, M., Bonacin, R., Donadi, E. A., Passos, G. A.
10.1101/2023.09.11.557161 — Posted: 2023-09-11
Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1
Hu, Y., Zou, J., Kurhade, C., Deng, X., Chang, H. C., Kim, D. K., Shi, P.-Y., Ren, P., Xie, X.
10.1101/2023.09.10.557047 — Posted: 2023-09-11
Contrasting Effects of SARS-CoV-2 Vaccination vs. Infection on Antibody and TCR Repertoires
Braun, J., Hill, E. D., Contreras, E., Yasuda, M., Morgan, A., Ditelberg, S., Winter, E., Callahan, C., Mazzoni, G., Kirmaier, A., Mirebrahim, H., Asgharian, H., Telman, D., Collier, A.-R. Y., Barouch, D. H., Riedel, S., Dutta, S., Rubelt, F., Arnaout, R.
10.1101/2023.09.08.556703 — Posted: 2023-09-11
Enhanced Omicron subvariant cross-neutralization efficacy of a monovalent SARS-CoV-2 BA.4/5 mRNA vaccine encoding a noncleaved, nonfusogenic spike antigen
Seo, H. Y., Jung, H., Woo, H., Jung, H.-G., Bak, Y., Lee, S.-Y., Son, Y.-M., Yoon, G., Son, Y.-M., Hwang, S.-Y., Park, I., Shin, J.-S., Oh, J.-W.
10.1101/2023.09.10.557088 — Posted: 2023-09-11
Protocol for primary human lung organoid-derived air-liquid interface in vitro model to study response to SARS-CoV-2
Castaneda, D. C., Jangra, S., Yurieva, M., Martinek, J., Callender, M., Coxe, M., Choi, A., Diego, J. G.-B., Wu, T.-C., Marches, F., Chaussabel, D., Garcia-Sastre, A., Schotsaert, M., Williams, A., Palucka, K.
10.1101/2023.09.10.557067 — Posted: 2023-09-11
Bayesian phylogenetics on globally emerging SARS-CoV-2 variant BA.2.86 suggest global distribution and rapid evolution
Rothstein, A. P., Qiu, X., Robison, K., Collins, S., Muir, G., Lu, B., Plocik, A., Simen, B., Philipson, C.
10.1101/2023.09.08.556912 — Posted: 2023-09-11
The role of ion dissolution in metal and metal oxide surface inactivation of SARS-CoV-2
Hilton, J., Nanao, Y., Flokstra, M., Askari, M., Smith, T. K., Di Falco, A., King, P. D., Wahl, P., Adamson, C. S.
10.1101/2023.09.08.556901 — Posted: 2023-09-11
Brain infection by wild-type SARS-CoV-2 and the B.1.617.2 and B.1.1.529 variants of concern is a severe outcome in K18-hACE2 transgenic mice
Yicheng He, Y., Henley, J. E., Sell, P., Comai, L.
10.1101/2023.09.08.556906 — Posted: 2023-09-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).